We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
LUCY | Innovative Eyewear Inc | 0.6024 | 0.4164 | 223.87% | 443,318,473 |
AKAN | Akanda Corporation | 3.75 | 1.36 | 56.90% | 33,847,302 |
ONMD | OneMedNet Corporation | 2.296 | 0.826 | 56.19% | 103,142,569 |
MRUS | Merus NV | 60.11 | 16.04 | 36.40% | 4,591,529 |
NCPL | Netcapital Inc | 0.2369 | 0.0621 | 35.53% | 165,281,962 |
ISSC | Innovative Solutions and Support Inc | 6.62 | 1.63 | 32.67% | 510,173 |
TKLF | Yoshitsu Company Ltd | 0.3012 | 0.0732 | 32.11% | 57,245,991 |
AEI | Alset Inc | 0.7001 | 0.1701 | 32.09% | 497,889 |
ONCO | Onconetix Inc | 0.18 | 0.0386 | 27.30% | 27,330,948 |
LIDR | AEye Inc | 3.515 | 0.725 | 25.99% | 3,918,208 |
AGBA | AGBA Group Holding Ltd | 2.65 | 0.48 | 22.12% | 1,368,643 |
Exicure, Inc. (“Exicure” or the “Company”) (Nasdaq: XCUR), announced today it received notice of a delisting determination (the “Staff Delisting Determination”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”). The Staff Delisting Determination notified the Company that since it has not yet filed its Form 10-K for the year ended December 31, 2023 (the “Form 10-K”) per Nasdaq Listing Rule 5250(c)(1) (the “Rule”) by Nasdaq’s extended deadline of May 20, 2024 pursuant to the previously granted exception, trading of the Company’s common stock would be suspended from The Nasdaq Capital Market at the opening of business ...
TriSalus Life Sciences® Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, announced today that it has commenced an exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its warrants (the “Warrants”) identified in the Prospectus/Offer to Exchange (as defined below). The purpose of the Offer and Consent Solicitation is to simplify the Company’s capital structure and reduce the potential dilutive impact of the Warrants, thereby providing the Company with more flexibility for financing its operations in the future.
The SD7 Wired Palm Mic Pro leverages advanced AI to adjust and compensate microphone levels, ensuring that only the human voice is isolated and transmitted, while background noises—whether stationary or dynamic—are effectively suppressed. This sophisticated technology also normalizes voice levels, maintaining smooth conversation quality regardless of the speaker's proximity to the microphone. The Company also offers a VK7 Wired Palm Mic Pro with AI Noise Cancelation, so that this same innovative noise cancelation is available for first responder vehicles, and for enterprise vehicles with the Siyata VK7 Vehicle Kit.
PLEASANTON, Calif., May 24, 2024 /PRNewswire/ -- Workday, Inc. (NASDAQ: WDAY), a leading provider of solutions to help organizations manage their people and money, today announced that Carl Eschenbach, CEO, Workday, will present at the Jefferies Software Conference on May 29, 2024 at 9:00 a.m. Pacific Time / 12:00 p.m. Eastern Time. There will also be a live webcast of the event, available here.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 68,135.43 | 210.85 | 0.31% | 1.34T | 5,704,663,302 |
ETH | Ethereum | 3,676.87 | -98.65 | -2.61% | 440.53B | 9,184,313,401 |
USDT | Tether USD | 0.99959 | 0.00013 | 0.01% | 97.8B | 318,670,093 |
BNB | Binance Coin | 596.36 | -2.40 | -0.40% | 94.04B | 420,150,562 |
SOL | Solana | 165.87 | -10.13 | -5.76% | 72.88B | 1,922,698,915 |
STETH | stETH | 3,675.67 | -98.72 | -2.62% | 36.03B | 54,429,808 |
XRP | Ripple | 0.5314 | 0.0029 | 0.55% | 28.94B | 567,659,188 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 28.07B | 1,604,034,710 |
DOGE | Dogecoin | 0.16527 | 0.00564 | 3.53% | 23.56B | 1,008,715,881 |
TONCOIN | Wrapped TON Coin | 6.22 | 0.005507 | 0.09% | 21.58B | 120,508,027 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions